US Stock MarketDetailed Quotes
COLL Collegium Pharmaceutical
- 29.960
- -0.450-1.48%
Close Nov 22 16:00 ET
- 30.523
- +0.563+1.88%
Pre 08:00 ET
966.22MMarket Cap12.80P/E (TTM)
30.755High29.800Low394.16KVolume30.400Open30.410Pre Close11.85MTurnover1.31%Turnover Ratio23.22P/E (Static)32.25MShares42.28752wk High4.12P/B904.91MFloat Cap25.21052wk Low--Dividend TTM30.20MShs Float42.287Historical High--Div YieldTTM3.14%Amplitude7.370Historical Low30.066Avg Price1Lot Size
About Collegium Pharmaceutical Company
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Company Profile
SymbolCOLL
Company NameCollegium Pharmaceutical
Listing DateMay 7, 2015
Issue Price12.00
Founded2002
CEOMr. Vikram Karnani
MarketNASDAQ
Employees197
Fiscal Year Ends12-31
Address100 Technology Center Drive,Suite 300
CityStoughton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02072
Phone1-781-713-3699
Company Executives
- Name
- Position
- Salary
- Vikram Karnani
- Director, President and Chief Executive Officer
- --
- Colleen Tupper
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.73M
- Scott Dreyer
- Executive Vice President and Chief Commercial Officer
- 2.61M
- Dr. Thomas B. Smith, M.D.
- Executive Vice President and Chief Medical Officer
- 2.04M
- Shirley R. Kuhlmann
- Executive Vice President, General Counsel, Secretary and Chief Administrative Officer
- 2.87M
- Michael T. Heffernan, R.Ph.
- Chairman of the Board
- 330.61K
- Gwen A. Melincoff
- Independent Director
- 275.61K
- Dr. John A. Fallon, M.D.
- Independent Director
- 289.61K
- Gino Santini
- Lead Independent Director
- 322.61K
- Garen G. Bohlin
- Independent Director
- 299.61K
- Dr. Rita Balice-Gordon, PhD
- Independent Director
- 275.61K
- Dr. John G. Freund,M.D.
- Independent Director
- 298.61K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data